President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases. 

The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.

"We're going to be able to make that drug available almost immediately," Trump said. 

The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.

He also tempered the president's optimism about the still-untested solution. 

"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."

New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.  

"The therapies are something we could move on much faster potentially," Trump said. 

He claimed the administration "slashed red tape" to develop new vaccines and therapies.

The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks

"If we find that we need something, then we will do that," he said.  

Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak. 

The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.

"We continue our relentless effort to defeat the Chinese virus," Trump said.

Share:
More In Politics
Gov. Newsom Could Win Most Votes and Still Lose to Republican Candidate
California Governor Gavin Newsom is facing a recall election in about two weeks. Newsom was elected governor in 2018 with nearly 62% of the vote after working as lieutenant governor for eight years. However, his popularity took a hit after his handling of Covid-19 pandemic, although the White House is refusing to cite this as the direct reason for the September 14th recall election. There are 46 candidates running to be Newsom's replacement, and some are saying that California could end up electing a republican governor. Jeremy White, California politics reporter and co-writer of daily California Playbook Newsletter at Politico, joined Cheddar Politics to discuss more about the election and its possible outcomes.
Fukushima Nuclear Water to Be Released Via Undersea Tunnel
The operator of the wrecked Fukushima nuclear power plant says it plans to build an undersea tunnel so that massive amounts of treated but still radioactive water can be released into the ocean about 1 kilometer (0.6 mile) away from the plant to avoid interference with local fishing.
Kabul Airport Attack Kills 60 Afghans, 12 U.S. Troops
Two suicide bombers and gunmen have targeted crowds of Afghans flocking to Kabul’s airport, in the waning days of a massive airlift that has drawn thousands of people seeking to flee the Taliban takeover of Afghanistan.
U.S. Jobless Claims Rise by 4,000 to 353,000
The number of Americans applying for unemployment benefits rose for the first time in five weeks even though the economy and job market have been recovering briskly from the coronavirus pandemic.
Load More